Business Context and Reporting Period
This Form 8-K filing by Globus Medical, Inc. reports on the results of the Annual Meeting of Stockholders held on June 4, 2013. The filing details the voting outcomes for four specific proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and stockholder voting results.
Material Changes and Voting Results
The following proposals were voted upon and approved by stockholders:
- Proposal 1 (Election of Directors): Three individuals were elected to serve three-year terms on the Board of Directors:
- David C. Paul: 281,152,017 votes For; 9,629,890 votes Against.
- Daniel T. Lemaitre: 290,671,333 votes For; 98,111 votes Against.
- Ann D. Rhoads: 290,623,417 votes For; 146,027 votes Against.
- Proposal 2 (Ratification of Auditors): Ratified the appointment of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2013.
- Votes For: 311,434,864
- Votes Against: 16,258
- Proposal 3 (Executive Compensation): Approved the non-binding advisory vote on the compensation of named executive officers.
- Votes For: 289,877,196
- Votes Against: 7,578
- Proposal 4 (Frequency of Compensation Votes): Approved a 1-year frequency for future stockholder advisory votes on executive compensation.
- Votes for 1 Year: 290,625,507
- Votes for 2 Years: 13,260
- Votes for 3 Years: 139,742
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the tabulation of votes cast at the Annual Meeting.
Important Facts for Investors to Verify
- Confirmation that the newly elected directors (Paul, Lemaitre, Rhoads) have accepted their positions and will commence their three-year terms.
- Verification that KPMG LLP has formally accepted the appointment as the independent auditor for the fiscal year ending December 31, 2013.
- Review of the company's future proxy materials to ensure the 1-year frequency for executive compensation votes is implemented as approved.